On Monday 25 July, China approved the use of the drug “Azvudine” to treat “normal” – i.e. non-severe – forms of Covid-19.
Manufactured by the Chinese laboratory Genuine Biotech, the originality of the treatment lies in the fact that it is initially used against HIV. Are we to understand that history is proving the late Professor Montagnier right, as Gérard Guillaume predicted?
At the beginning of July, while the laboratory reported good results against “normal” forms of the infection, Azvudine was initially rejected by the Chinese government because it could not treat severe forms. Eventually, the National Medical Products Administration gave a conditional green light to treat adult patients with “normal type” Covid, as reported by the British news agency Reuters. Azvudine, taken orally and used early, has some similarities to Ivermectin, another drug that has struggled to win the favour of health authorities.
However, Genuine Biotech’s treatment has one major difference: it is initially used against the AIDS virus, HIV (human immunodeficiency virus). However, as early as 2020, Professor Montagnier supported the hypothesis that Covid-19 had been manufactured in the laboratory, in particular with HIV sequences: “It’s not natural, it’s the work of a professional, a molecular biologist, a sequence watchmaker. For what purpose? One of my hypotheses is that they wanted to make an AIDS vaccine,” he explained in August of the same year, after conducting his own research.
If the Nobel Prize winner was set on fire by the press and the “scientific community” for defending this thesis – too soon – he persisted. Shortly before his death, he stated that patients and vaccinees (affected by the virus’s Spike protein) often showed signs of immunodeficiency, and recommended that everyone be tested for HIV.
Today, the approval of this anti-HIV drug, to fight Covid-19, seems to prove him right. And it is not the only one! Indeed, both the United States and the French National Authority for Health (HAS) recommend Paxlovid (a Pfizer drug that has just been approved for the treatment of Covid), which contains Ritonavir, an active substance with therapeutic effect used against HIV. Some people are concerned about these developments:
Originally published in France Soir.